+44%

est. 2Y upside i

HealthcareAI & MLSeries A

Medical language models to automate healthcare operations

Rank

#1085

Sector

Healthtech, Artificial Intelligence

Est. Liquidity

~2Y

Data Quality

Data: Medium

Latent Health offers high-risk, high-reward equity upside with an expected return of ~44% over 2 years.

Last updated: July 19, 2026

Bull (30%)+220%

AI tailwinds sustain the 30x multiple; revenue reaches $68M, valuation $2.04B. Net upside 220% after 20pp dilution.

Base (45%)-7%

Multiple compresses to 10x (premium to comps) on $68M revenue, valuation $680M. Net downside -6.7% after dilution.

Bear (25%)-75%

Multiple collapses to 4x on $68M revenue, valuation $272M. Net downside -74.7% after dilution; preference stack not triggered.

Est. time to liquidity~2.0 years

Preference Stack Risk

moderate

Funding Intensity

1550%

Total funding of $93.1M represents 15.5% of entry valuation, moderate preference overhang.

Dilution Risk

high

Likely Series B within 24 months; assumes 20 percentage point dilution from new rounds and option pool expansion.

Secondary Liquidity

none

No secondary market activity detected; no liquidity until a future exit event.

Questions to Ask at the Interview

Strategic questions based on Latent's data — designed to show you've done your homework.

  • 1

    “How do you plan to sustain a 30x revenue multiple as the company scales?”

  • 2

    “What is the strategy to achieve profitability and reduce dependency on venture capital?”

  • 3

    “What is the expected timeline to liquidity, and are there any secondary market opportunities?”

Community

Valuation Sentiment

Our model estimates +44% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.